IE920900A1 - Heterocyclic compounds, their preparation and pharmaceutical¹use - Google Patents

Heterocyclic compounds, their preparation and pharmaceutical¹use

Info

Publication number
IE920900A1
IE920900A1 IE920900A IE920900A IE920900A1 IE 920900 A1 IE920900 A1 IE 920900A1 IE 920900 A IE920900 A IE 920900A IE 920900 A IE920900 A IE 920900A IE 920900 A1 IE920900 A1 IE 920900A1
Authority
IE
Ireland
Prior art keywords
group
carbon atoms
compounds according
alkyl
compound
Prior art date
Application number
IE920900A
Other languages
English (en)
Inventor
Susan Elaine Barrie
Michael Jarman
Raymond Mccague
Gerard Andrew Potter
Martin George Rowlands
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919106031A external-priority patent/GB9106031D0/en
Priority claimed from GB919125308A external-priority patent/GB9125308D0/en
Application filed by British Tech Group filed Critical British Tech Group
Publication of IE920900A1 publication Critical patent/IE920900A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IE920900A 1991-03-22 1992-03-20 Heterocyclic compounds, their preparation and pharmaceutical¹use IE920900A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919106031A GB9106031D0 (en) 1991-03-22 1991-03-22 Heterocyclic compounds,their preparation and pharmaceutical use
GB919125308A GB9125308D0 (en) 1991-11-28 1991-11-28 Heterocyclic compounds,their preparation and pharmaceutical use

Publications (1)

Publication Number Publication Date
IE920900A1 true IE920900A1 (en) 1992-09-23

Family

ID=26298616

Family Applications (1)

Application Number Title Priority Date Filing Date
IE920900A IE920900A1 (en) 1991-03-22 1992-03-20 Heterocyclic compounds, their preparation and pharmaceutical¹use

Country Status (7)

Country Link
EP (1) EP0594629A1 (fr)
AU (1) AU1417592A (fr)
GB (1) GB2253851B (fr)
IE (1) IE920900A1 (fr)
NZ (1) NZ242054A (fr)
PT (1) PT100275A (fr)
WO (1) WO1992016507A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510284A (ja) * 1991-08-22 1994-11-17 カイロサイエンス・リミテッド キラルグルタレートエステル、それらの分割および誘導されるグルタルイミド化合物
DK1302461T3 (da) * 2000-05-31 2008-01-28 Santen Pharmaceutical Co Ltd TNF-alfa-produktionsinhibitorer
JP2008007404A (ja) * 2004-10-08 2008-01-17 Nippon Kayaku Co Ltd 新規ピリジン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
CA1280414C (fr) * 1985-03-15 1991-02-19 Saichi Matsumoto Derives d'isoprenoidamine et agents anti-ulcereux
IL83163A (en) * 1986-07-18 1991-06-10 Erba Carlo Spa Cycloalkyl-substituted 4-pyridyl derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GB2253851A (en) 1992-09-23
GB9206062D0 (en) 1992-05-06
AU1417592A (en) 1992-10-21
NZ242054A (en) 1993-11-25
GB2253851B (en) 1993-10-06
PT100275A (pt) 1993-06-30
EP0594629A1 (fr) 1994-05-04
WO1992016507A1 (fr) 1992-10-01

Similar Documents

Publication Publication Date Title
US4377584A (en) 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
Rowlands et al. Esters of 3-pyridylacetic acid that combine potent inhibition of 17. alpha.-Hydroxylase/C17, 20-lyase (Cytochrome P45017. alpha.) with resistance to esterase hydrolysis
US5494914A (en) Inhibitors for testosterone 5α-reductase activity
US5155107A (en) 17β-substituted-4-aza-5α-androstan-3-one derivatives and process for their preparation
McCague et al. Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid
áJohn Smith et al. Inhibitors of enzymes of androgen biosynthesis: cytochrome P450 17α and 5 α-steroid reductase
JPH05213989A (ja) １７β−置換アザーアンドロスタン誘導体
IE920900A1 (en) Heterocyclic compounds, their preparation and pharmaceutical¹use
US5143926A (en) Substituted pyridine-2,4-dicarboxylic acid compounds and methods of use thereof
IL98999A (en) 4-amino-delta 4-steroids process for their prepar ation and their use as 5alpha-reductase inhibitors
EP0640072B1 (fr) Dérivés de pyridine comme inhibiteurs de la hydroxylase et lyase
DE69422629T2 (de) Indolderivate als 5-alpha-reductase-1 inhibitoren
AU696320B2 (en) 4-aza-19-norandrostane derivatives
JPH04330060A (ja) ピリジン−２，４−および−２，５−ジカルボン酸のジ（ニトロキシアルキル）アミド、その製造方法およびその使用
US5071857A (en) 2,6-dioxopiperidine derivatives, their preparation and pharmaceutical compositions containing them
IE861970L (en) Steroidal aromatase inhibitors
EP0147121B1 (fr) Dérivés de pipéridine-2,6-dioxo, leur préparation et compositions pharmaceutiques qui les contiennent
WO1992013828A1 (fr) Nouveau derive de benzanilide ou son sel
AU637848B2 (en) Pyridine-2,4- and 2,5-dicarboxamides, a process for the preparation thereof, and the use thereof
JPS60222497A (ja) ５αリダクターゼの阻害剤としての１７β―Ｎ―モノ置換カルバモイル―４―アザ―５α―アンドロスタ―１―エン―３―オン類
AU718358B2 (en) Inhibitors of testosterone 5-alpha reductase activity
NZ280175A (en) Inhibiting testosterone 5alpha-reductase activity using an A ring modified 4-aza-3-oxo-cyclopentanoperhydrophenarthrene substituted in position-17beta by amino or acylamino
GB2266887A (en) Substituted pyridines, their preparation and pharmaceutical use
IL101257A (en) 2, 4 - and -2,5 - pyridine dicarboxyamides, a process for preparing them, the use thereof and pharmaceutical compositions based on these compounds
GB2273096A (en) Piperido(4',3':16,17)-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation